MedPath

The utility and safety of intraperitoneal administration by microbubble agents for cirrhosis with refractory ascites

Not Applicable
Recruiting
Conditions
Cirrhosis with refractory ascites
Registration Number
JPRN-UMIN000014861
Lead Sponsor
Chiba University Graduate School of Medicine, Department of Gastroenterology and Nephrology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to public recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

Cirrotic patients with refractory ascites

Exclusion Criteria

?Child-Pugh grade C
?Egg allergy
?Spontaneous bacterial peritonitis

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.